Royal Bank of Canada trimmed its price target for Exelixis in a research report.
1 report, 1 independent
Updated Oct 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada trimmed its price target for Exelixis in a research report.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Exelixis
American biotechnology company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Royal Bank of Canada upped its target price for Citizens Financial Group.
- Royal Bank of Canada decreased its price target for BOK Financial on October 17, 2026.
- Royal Bank of Canada raised its target price for DCH.
- Royal Bank of Canada reduced its target price for Tenet Healthcare.
- Royal Bank of Canada lifted its target price for MMM.